APA

Frick L. W., St John L., Taylor L. C., Painter G. R., Furman P. A., Liotta D. C., Furfine E. S. & Nelson D. J. (19940217). Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. : Antimicrobial agents and chemotherapy.

Chicago

Frick L W, St John L, Taylor L C, Painter G R, Furman P A, Liotta D C, Furfine E S and Nelson D J. 19940217. Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. : Antimicrobial agents and chemotherapy.

Harvard

Frick L. W., St John L., Taylor L. C., Painter G. R., Furman P. A., Liotta D. C., Furfine E. S. and Nelson D. J. (19940217). Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. : Antimicrobial agents and chemotherapy.

MLA

Frick L W, St John L, Taylor L C, Painter G R, Furman P A, Liotta D C, Furfine E S and Nelson D J. Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. : Antimicrobial agents and chemotherapy. 19940217.